Table 1.
Clinical and paraclinical characteristics of NT1 patients and controls included in the study.
| Patients with narcolepsy type 1 | Controls | |||
|---|---|---|---|---|
| Cohort 1 (n=10) | Cohort 2 (n=11) | Subjects with somatoform disorders (n=10) | Patients with other sleep disorders (n=12) | |
| Mean of age (Years ± SEM) | 24.5 ± 5.11 | 25.19 ± 3.48 | 27.8 ± 3.6 | 26.85 ± 3.44 |
| Sex (Female/Male) | 3/7 | 3/8 | 3/7 | 9/3 |
| Time from NT1 onset (Years) | 4.24 ± 1.22 | 2.85 ± 0.95 | —– | —– |
| Cataplexy | 10/10 | 10/11 | 0/10 | 0/12 |
| HLA-DQB1*06:02 positive | 10/10 | 11/11 | NA | 3/12 |
| CSF Orexin levels < 110pg/ml | 10/10 | 11/11 | NA | 0/12 |
NA, not available.